ABOGENBIO

pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; cultures of microorganisms for medical or veterinary use; biological preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of viral disease, lipid particle for nucleotide drug delivery purpose and nucleotide; biochemical medicines for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; dietetic substances being foods and beverages adapted for medical use

Technological research in the field of medical research; quality control for others; product quality testing; cancer research for medical purposes; pharmaceutical drug development services; pharmaceutical product evaluation, namely, drug evaluation; pharmaceutical research services; medical research; development of pharmaceutical preparations and pharmaceuticals